- Research works
- 5 ▲ 300% vs 2013–17
- Citations
- 57 12.6 per fractional work
- Top-10% rate
- 33.6% record average 16.5%
- Open access
- 77% world 28%
Not ranked overall: Bio Tissue (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Bio Tissue (United States) publish most on?
By volume in 2022–2025: Ophthalmology and Visual Impairment Studies, Innovative Microfluidic and Catalytic Techniques Innovation, Glaucoma and retinal disorders and Corneal surgery and disorders.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Ophthalmology and Visual Impairment Studies Epidemiology 1 works
- 2 Innovative Microfluidic and Catalytic Techniques Innovation Biomedical Engineering 0 works
- 3 Glaucoma and retinal disorders Ophthalmology 0 works
- 4 Corneal surgery and disorders Radiology, Nuclear Medicine and Imaging 0 works
- 5 Pickering emulsions and particle stabilization Materials Chemistry 0 works
- 6 Electrohydrodynamics and Fluid Dynamics Electrical and Electronic Engineering 0 works
- 7 Ocular Surface and Contact Lens Public Health, Environmental and Occupational Health 0 works
- 8 Corneal Surgery and Treatments Radiology, Nuclear Medicine and Imaging 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Bio Tissue (United States)'s research output changed?
Output in 2018–2022 was 300% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Doral
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.